NCT00436215 2020-11-23
Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
3 trialsNCT00238121 2015-11-20
Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00096395 2013-06-13
Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer
National Cancer Institute (NCI)
Phase 2 Completed